Avidity Partners Management LP Ac Immune Sa Transaction History

Avidity Partners Management LP

$2.03 Billion
Q2 2024

A detailed history of Avidity Partners Management LP transactions in Ac Immune Sa stock. As of the latest transaction made, Avidity Partners Management LP holds 825,000 shares of ACIU stock, worth $2.43 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

825,000

Previous 4,470,000 81.54%

Holding current value

$2.43 Million

Previous $13.2 Million 75.13%

% of portfolio

0.16%

Previous 0.51%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.29 - $4.87 $8.35 Million - $17.8 Million	-3,645,000 Reduced 81.54%	825,000 $3.29 Million
Q1 2024 May 15, 2024	BUY	$2.66 - $4.87 $2,447 - $4,480	920 Added 0.02%	4,470,000 $13.2 Million
Q4 2023 Feb 14, 2024	BUY	$2.46 - $5.0 $3.69 Million - $7.5 Million	1,499,280 Added 50.48%	4,469,080 $22.3 Million
Q3 2023 Nov 14, 2023	BUY	$2.77 - $3.38 $184,265 - $224,844	66,522 Added 2.29%	2,969,800 $8.46 Million
Q2 2023 Aug 14, 2023	BUY	$1.85 - $3.4 $4.77 Million - $8.76 Million	2,577,878 Added 792.22%	2,903,278 $8.59 Million
Q4 2022 Feb 14, 2023	BUY	$1.72 - $3.12 $86,901 - $157,634	50,524 Added 18.38%	325,400 $663,000
Q3 2022 Nov 14, 2022	BUY	$2.4 - $3.64 $659,702 - $1 Million	274,876 New	274,876 $869,000
Q4 2021 Feb 14, 2022	SELL	$4.83 - $7.56 $8.4 Million - $13.2 Million	-1,739,600 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.2 - $8.34 $964,720 - $1.3 Million	155,600 Added 9.82%	1,739,600 $11.7 Million
Q2 2021 Aug 16, 2021	BUY	$6.04 - $8.37 $9.57 Million - $13.3 Million	1,584,000 New	1,584,000 $12.6 Million
Q4 2020 Feb 16, 2021	SELL	$4.47 - $5.58 $6.93 Million - $8.65 Million	-1,550,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.78 - $9.06 $7.41 Million - $14 Million	1,550,000 New	1,550,000 $7.56 Million

Others Institutions Holding ACIU

# of Institutions

Shares Held

28.3M

Call Options Held

163K

Put Options Held

37.6K

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $245M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Account

Avidity Partners Management LP Ac Immune Sa Transaction History